Genetically encoded immunophotosensitizer 4D5scFv-miniSOG is a highly selective agent for targeted photokilling of tumor cells in vitro

Kristina E. Mironova, Galina M. Proshkina, Anastasiya V. Ryabova, Oleg A. Stremovskiy, Sergey A. Lukyanov, Rem V. Petrov, Sergey M. Deyev

Результат исследований: Материалы для журналаСтатья

55 Цитирования (Scopus)

Выдержка

Tumor-targeted delivery of cytotoxins presents considerable advantages over their passive transport. Chemical conjugation of cytotoxic module to antibody is limited due to insufficient reproducibility of synthesis, and recombinant immunotoxins are aimed to overcome this disadvantage. We obtained genetically encoded immunophotosensitizer 4D5scFv-miniSOG and evaluated its photocytotoxic effect in vitro. A single-chain variable fragment (scFv) of humanized 4D5 antibody was used as a targeting vehicle for selective recognition of the extracellular domain of human epidermal growth factor receptor 2 (HER2/neu) overexpressed in many human carcinomas. As a phototoxic module we used a recently described photoactivated fluorescent flavoprotein miniSOG. We found that recombinant protein 4D5scFv-miniSOG exerts a highly specific photo-induced cytotoxic effect on HER2/neu-positive human breast adenocarcinoma SK-BR-3 cells (IC50= 160 nM). We demonstrated that the 4D5scFv-miniSOG specifically binds to HER2-positive cells and internalizes via receptor-mediated endocytosis. Co-treatment of breast cancer cells with 4D5scFv-miniSOG and Taxol or junction opener protein JO-1 produced remarkable additive effects.

Язык оригиналаАнглийский
Страницы (с-по)831-840
Число страниц10
ЖурналTheranostics
Том3
Номер выпуска11
DOI
СостояниеОпубликовано - 2013
Опубликовано для внешнего пользованияДа

Отпечаток

Antibodies, Monoclonal, Humanized
Immunotoxins
Flavoproteins
Single-Chain Antibodies
Neoplasms
Cytotoxins
Endocytosis
Paclitaxel
Recombinant Proteins
Inhibitory Concentration 50
Adenocarcinoma
Breast
Breast Neoplasms
Carcinoma
Antibodies
In Vitro Techniques
Proteins
human ERBB2 protein

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Цитировать

Genetically encoded immunophotosensitizer 4D5scFv-miniSOG is a highly selective agent for targeted photokilling of tumor cells in vitro. / Mironova, Kristina E.; Proshkina, Galina M.; Ryabova, Anastasiya V.; Stremovskiy, Oleg A.; Lukyanov, Sergey A.; Petrov, Rem V.; Deyev, Sergey M.

В: Theranostics, Том 3, № 11, 2013, стр. 831-840.

Результат исследований: Материалы для журналаСтатья

Mironova, KE, Proshkina, GM, Ryabova, AV, Stremovskiy, OA, Lukyanov, SA, Petrov, RV & Deyev, SM 2013, 'Genetically encoded immunophotosensitizer 4D5scFv-miniSOG is a highly selective agent for targeted photokilling of tumor cells in vitro', Theranostics, том. 3, № 11, стр. 831-840. https://doi.org/10.7150/thno.6715
Mironova, Kristina E. ; Proshkina, Galina M. ; Ryabova, Anastasiya V. ; Stremovskiy, Oleg A. ; Lukyanov, Sergey A. ; Petrov, Rem V. ; Deyev, Sergey M. / Genetically encoded immunophotosensitizer 4D5scFv-miniSOG is a highly selective agent for targeted photokilling of tumor cells in vitro. В: Theranostics. 2013 ; Том 3, № 11. стр. 831-840.
@article{baf861e8f662464c99369fd787982543,
title = "Genetically encoded immunophotosensitizer 4D5scFv-miniSOG is a highly selective agent for targeted photokilling of tumor cells in vitro",
abstract = "Tumor-targeted delivery of cytotoxins presents considerable advantages over their passive transport. Chemical conjugation of cytotoxic module to antibody is limited due to insufficient reproducibility of synthesis, and recombinant immunotoxins are aimed to overcome this disadvantage. We obtained genetically encoded immunophotosensitizer 4D5scFv-miniSOG and evaluated its photocytotoxic effect in vitro. A single-chain variable fragment (scFv) of humanized 4D5 antibody was used as a targeting vehicle for selective recognition of the extracellular domain of human epidermal growth factor receptor 2 (HER2/neu) overexpressed in many human carcinomas. As a phototoxic module we used a recently described photoactivated fluorescent flavoprotein miniSOG. We found that recombinant protein 4D5scFv-miniSOG exerts a highly specific photo-induced cytotoxic effect on HER2/neu-positive human breast adenocarcinoma SK-BR-3 cells (IC50= 160 nM). We demonstrated that the 4D5scFv-miniSOG specifically binds to HER2-positive cells and internalizes via receptor-mediated endocytosis. Co-treatment of breast cancer cells with 4D5scFv-miniSOG and Taxol or junction opener protein JO-1 produced remarkable additive effects.",
keywords = "HER2/neu, Immunophototoxin, Phototoxicity, Single-chain variable fragment., Tumor-targeted delivery",
author = "Mironova, {Kristina E.} and Proshkina, {Galina M.} and Ryabova, {Anastasiya V.} and Stremovskiy, {Oleg A.} and Lukyanov, {Sergey A.} and Petrov, {Rem V.} and Deyev, {Sergey M.}",
year = "2013",
doi = "10.7150/thno.6715",
language = "English",
volume = "3",
pages = "831--840",
journal = "Theranostics",
issn = "1838-7640",
publisher = "Ivyspring International Publisher",
number = "11",

}

TY - JOUR

T1 - Genetically encoded immunophotosensitizer 4D5scFv-miniSOG is a highly selective agent for targeted photokilling of tumor cells in vitro

AU - Mironova, Kristina E.

AU - Proshkina, Galina M.

AU - Ryabova, Anastasiya V.

AU - Stremovskiy, Oleg A.

AU - Lukyanov, Sergey A.

AU - Petrov, Rem V.

AU - Deyev, Sergey M.

PY - 2013

Y1 - 2013

N2 - Tumor-targeted delivery of cytotoxins presents considerable advantages over their passive transport. Chemical conjugation of cytotoxic module to antibody is limited due to insufficient reproducibility of synthesis, and recombinant immunotoxins are aimed to overcome this disadvantage. We obtained genetically encoded immunophotosensitizer 4D5scFv-miniSOG and evaluated its photocytotoxic effect in vitro. A single-chain variable fragment (scFv) of humanized 4D5 antibody was used as a targeting vehicle for selective recognition of the extracellular domain of human epidermal growth factor receptor 2 (HER2/neu) overexpressed in many human carcinomas. As a phototoxic module we used a recently described photoactivated fluorescent flavoprotein miniSOG. We found that recombinant protein 4D5scFv-miniSOG exerts a highly specific photo-induced cytotoxic effect on HER2/neu-positive human breast adenocarcinoma SK-BR-3 cells (IC50= 160 nM). We demonstrated that the 4D5scFv-miniSOG specifically binds to HER2-positive cells and internalizes via receptor-mediated endocytosis. Co-treatment of breast cancer cells with 4D5scFv-miniSOG and Taxol or junction opener protein JO-1 produced remarkable additive effects.

AB - Tumor-targeted delivery of cytotoxins presents considerable advantages over their passive transport. Chemical conjugation of cytotoxic module to antibody is limited due to insufficient reproducibility of synthesis, and recombinant immunotoxins are aimed to overcome this disadvantage. We obtained genetically encoded immunophotosensitizer 4D5scFv-miniSOG and evaluated its photocytotoxic effect in vitro. A single-chain variable fragment (scFv) of humanized 4D5 antibody was used as a targeting vehicle for selective recognition of the extracellular domain of human epidermal growth factor receptor 2 (HER2/neu) overexpressed in many human carcinomas. As a phototoxic module we used a recently described photoactivated fluorescent flavoprotein miniSOG. We found that recombinant protein 4D5scFv-miniSOG exerts a highly specific photo-induced cytotoxic effect on HER2/neu-positive human breast adenocarcinoma SK-BR-3 cells (IC50= 160 nM). We demonstrated that the 4D5scFv-miniSOG specifically binds to HER2-positive cells and internalizes via receptor-mediated endocytosis. Co-treatment of breast cancer cells with 4D5scFv-miniSOG and Taxol or junction opener protein JO-1 produced remarkable additive effects.

KW - HER2/neu

KW - Immunophototoxin

KW - Phototoxicity

KW - Single-chain variable fragment.

KW - Tumor-targeted delivery

UR - http://www.scopus.com/inward/record.url?scp=84888797993&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888797993&partnerID=8YFLogxK

U2 - 10.7150/thno.6715

DO - 10.7150/thno.6715

M3 - Article

AN - SCOPUS:84888797993

VL - 3

SP - 831

EP - 840

JO - Theranostics

JF - Theranostics

SN - 1838-7640

IS - 11

ER -